GlassScriptPhysician profile
Priscilla Chow
NPI 1871024745
$7,618.45
in general payments reported to CMS, 2019-2025
29 companies · $1,599 in 2025
The $1,599 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $1,809 · 2023: $2,690 · 2024: $1,377 · 2025: $1,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,488 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,487.50 |
| Education | $178.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,060.27 | 2022-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,047.23 | 2022-2025 | Ofev, Jascayd |
| Astrazeneca Pharmaceuticals LP | $1,041.98 | 2022-2025 | Fasenra, Tezspire, Airsupra |
| Regeneron Healthcare Solutions, INC. | $495.44 | 2022-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $489.06 | 2022-2024 | Uptravi, Opsumit |
| Mylan Specialty L.P. | $274.37 | 2022-2024 | Yupelri |
| Genzyme Corporation | $142.77 | 2023-2025 | |
| Inspire Medical Systems, INC. | $136.29 | 2025 | Inspire |
| United Therapeutics Corporation | $133.60 | 2024-2025 | Tyvaso, Tyvaso |
| Paratek Pharmaceuticals, INC. | $123.97 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.66 | 2022-2023 | |
| Philips North America LLC | $70.31 | 2022-2025 | Vest Therapy Und |
| Axsome Therapeutics, INC. | $51.12 | 2025 | Sunosi |
| Insmed, INC. | $49.93 | 2023-2024 | Arikayce |
| Gilead Sciences, INC. | $47.96 | 2024 | Epclusa |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $43.36 | 2024-2025 | Smartvest |
| Grifols USA, LLC | $43.21 | 2025 | Prolastin-C Liquid |
| Janssen Pharmaceuticals, INC | $38.84 | 2022 | |
| Viatris Specialty LLC | $37.17 | 2025 | Yupelri |
| Amgen INC. | $33.12 | 2023-2025 | Tezspire |
| Harmony Biosciences LLC | $28.96 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.58 | 2022-2025 | Glassia |
| Ucb, INC. | $28.12 | 2024 | Briviact |
| Teva Pharmaceuticals USA, INC. | $19.41 | 2021 | |
| Jazz Pharmaceuticals INC. | $17.55 | 2025 | |
| Merck Sharp & Dohme LLC | $17.00 | 2023 | |
| Inogen, INC. | $16.25 | 2025 | |
| Vifor Pharma, INC. | $15.62 | 2025 | Zemaira |
| Lilly USA, LLC | $14.30 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscilla Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.